Special attention should be paid to patients with poor insight, increasing the cognitive aspects of the therapy in an attempt to modify the rigidity and fixity of their beliefs. In addition, male patients should be more observed, since they showed lower chance of response to GCBT when compared to women. Patients with more severe global symptoms (CGI) are poorer responders to GCBT, which indicates that not only obsessive-compulsive symptoms (OCS) should be evaluated, since other symptoms, such as depression and anxiety, may affect the treatment; therefore, an attempt to reduce these symptoms, prior to the treatment of OCD, should be considered as an option in some cases.
Objective: The present study was designed to evaluate the psychometric properties of the Brazilian Portuguese version of the ObsessiveCompulsive Inventory -Revised. Method: The Obsessive-Compulsive Inventory -Revised was administered to a total of 260 participants: a clinical sample of 130 patients with anxiety disorders (64 with a diagnosis of obsessive-compulsive disorder patients, 33 diagnosed with social phobia, and 33 with panic disorder) and a sample of 130 non-clinical subjects. Results: The findings indicate that the Obsessive-Compulsive Inventory -Revised is a valid measure for identifying and assessing the severity of the six symptom subtypes in obsessive-compulsive disorder. The original factor structure of the instrument was replicated in an exploratory factor analysis. Test-retest reliability was examined using data from 64 obsessive-compulsive disorder patients who completed the inventory on two different occasions. In each sample, the overall and subscale scores showed moderate to good internal consistency, good convergent and divergent validity, and sensitivity to changes resulting from cognitivebehavioral group therapy. Conclusion: Our findings indicate that the Brazilian Portuguese version of the Obsessive-Compulsive InventoryRevised retains the psychometric properties of its original version and the Spanish, German and Icelandic versions.
Descriptors
A b s t r a c t Objective: Obsessive-compulsive disorder affects between 1.6 and 3.1% of the population. Due to the distress caused by obsessive-compulsive disorder leading to disability as well as the prevalence of the disease, there has been an increase in the number of studies focusing on the general well-being of patients by assessing quality of life. Method: A literature review of the studies that investigated the quality of life of patients with obsessive-compulsive disorder was performed. The search was carried out in the following database: Medline, SciELO and PsychoInfo, and the following key-words were used "quality of life" AND "obsessive-compulsive disorder". Twenty-seven articles about the topic were selected. The results from this study describe the areas most severely affected by the disorder as well as the relationship between obsessive-compulsive disorder and quality of life. In addition, the effects of the treatment on the patients' quality of life are presented. Results: The social and familial relationships and the occupational performance (capacity to work and study) were the areas most severely affected by the disorder, and, although there was an improvement with the treatment, these areas remain at a poor level of performance. The obsessions were associated with the most significant impairment of the quality of life if compared to the compulsions (rituals). Conclusions:Results from the selected studies suggest that obsessive-compulsive disorder patients have an impairment of quality of life. The level of impairment is similar to that of schizophrenic patients. Future studies with different designs are necessary so that more consistent results can be established.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.